Skip to main content
DeutschDE
European Commission logo print header

Accelerated market launch of MedEye, a plug-and-play medication safety solution

Ziel

Medication errors occur daily and form a major burden to society. Medication errors often lead to adverse drug reactions, lengthened hospital stays, increased healthcare costs, and in the most severe cases, increased mortality. Medication errors pose a significant risk to the European population. It is estimated that 4,7 million Europeans are harmed by a medication error every year, which amounts to preventable healthcare costs in excess of €11 billion a year. Strikingly, around 50% of medication errors can be stopped at the patient’s bedside. MedEye is an innovative medication verification suite that scans, detects and verifies medication at the bedside. MedEye stops medication errors from taking place by verifying medication before it is administered to patients. MedEye has already been tested and validated in three Dutch hospitals with excellent results. In this project, activities will be performed to push MedEye onto the European market and facilitate its deployment on a large scale. MedEye will be integrated with IT systems that serve a major part of European medical centers. Developments will also be performed to enable the sale, deployment and support of MedEye through distributors. Two launching pilots will be performed to establish transnational proof of performance and cost-effectiveness, which will be instrumental in penetrating the European markets. Given the diversity of the European healthcare landscape, a thorough market research will be performed to gear the commercialization strategy towards individual countries. Together, the activities in this project will provide access to the main EU market and facilitate a wide deployment of MedEye throughout Europe.

Wissenschaftliches Gebiet

Programm/Programme

Thema/Themen

Aufforderung zur Vorschlagseinreichung

H2020-FTIPilot-2016

Andere Projekte für diesen Aufruf anzeigen

Unterauftrag

H2020-FTIPilot-2016-1

Finanzierungsplan

IA - Innovation action

Koordinator

MINT SOLUTIONS HOLLAND B.V.
Netto-EU-Beitrag
€ 485 122,00
Adresse
Europalaan 6
5232 BC 's-Hertogenbosch
Niederlande

Auf der Karte ansehen
KMU

Die Organisation definierte sich zum Zeitpunkt der Unterzeichnung der Finanzhilfevereinbarung selbst als KMU (Kleine und mittlere Unternehmen).
Ja
Region
Zuid-Nederland Noord-Brabant Noordoost-Noord-Brabant
Aktivitätstyp
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Gesamtkosten
€ 1 597 282,50

Beteiligte (7)

Diese Seite teilen

Herunterladen

Letzte Aktualisierung: 23 August 2022

Mein Booklet

Permalink: https://cordis.europa.eu/project/id/730731/de

European Union, 2024